Clinical data of the patient at admission and newborns at delivery
| Test . | Patient at admission . | 2nd newborn . | 3rd newborn . |
|---|---|---|---|
| WBC (×103/μL) | 6.13 | 4.40 | 14.5 |
| Hb (g/dL) | 10.7 | 15.9 | 18.3 |
| Plt (×103/μL) | 248 | 142 | 274 |
| Fib (mg/dL) | 290 | 63 | 102 |
| PT (%) | 87.7 | 36.6 | 44.2 |
| PT-INR | 1.08 | 1.79 | 1.48 |
| APTT (s) | 110.4 | >180 | 58.3 |
| FDP (μg/mL) | <2.5 | 15.6 | 77.2 |
| Alb (g/dL) | 4.3 | 3.6 | — |
| AST (U/L) | 21 | 30 | — |
| ALT (U/L) | 16 | 5 | — |
| LDH (U/L) | 261 | 429 | — |
| T-Bil (mg/dL) | 0.5 | 3.1 | — |
| Cre (mg/dL) | 0.65 | 0.81 | — |
| IgG (mg/dL) | 1019 | 459 | — |
| IgA (mg/dL) | 181 | 3 | — |
| IgM (mg/dL) | 102 | 0 | — |
| Anti-ds DNA Ab | Negative | — | — |
| Anti-CL B2MG Ab | Negative | — | — |
| Anti-CL IgG Ab | Negative | — | — |
| Lupus anticoagulant | Negative | — | — |
| Anti-SS-A, B Ab | Negative | — | — |
| Antinuclear antibody | Negative | — | — |
| VWF (%) | 88.2 | — | — |
| Factor VIII (%) | <1.0 | <1.0 | 45.9 |
| Factor VIII inhibitor (BU/mL) | 31.9 | <0.5 | <0.5 |
| Factor IX (%) | — | — | — |
| Factor IX inhibitor (BU/mL) | <0.5 | — | — |
| Factor XIII (%) | 130 | — | — |
| Hematuria | Negative | — | — |
| Proteinuria | Negative | — | — |
| Test . | Patient at admission . | 2nd newborn . | 3rd newborn . |
|---|---|---|---|
| WBC (×103/μL) | 6.13 | 4.40 | 14.5 |
| Hb (g/dL) | 10.7 | 15.9 | 18.3 |
| Plt (×103/μL) | 248 | 142 | 274 |
| Fib (mg/dL) | 290 | 63 | 102 |
| PT (%) | 87.7 | 36.6 | 44.2 |
| PT-INR | 1.08 | 1.79 | 1.48 |
| APTT (s) | 110.4 | >180 | 58.3 |
| FDP (μg/mL) | <2.5 | 15.6 | 77.2 |
| Alb (g/dL) | 4.3 | 3.6 | — |
| AST (U/L) | 21 | 30 | — |
| ALT (U/L) | 16 | 5 | — |
| LDH (U/L) | 261 | 429 | — |
| T-Bil (mg/dL) | 0.5 | 3.1 | — |
| Cre (mg/dL) | 0.65 | 0.81 | — |
| IgG (mg/dL) | 1019 | 459 | — |
| IgA (mg/dL) | 181 | 3 | — |
| IgM (mg/dL) | 102 | 0 | — |
| Anti-ds DNA Ab | Negative | — | — |
| Anti-CL B2MG Ab | Negative | — | — |
| Anti-CL IgG Ab | Negative | — | — |
| Lupus anticoagulant | Negative | — | — |
| Anti-SS-A, B Ab | Negative | — | — |
| Antinuclear antibody | Negative | — | — |
| VWF (%) | 88.2 | — | — |
| Factor VIII (%) | <1.0 | <1.0 | 45.9 |
| Factor VIII inhibitor (BU/mL) | 31.9 | <0.5 | <0.5 |
| Factor IX (%) | — | — | — |
| Factor IX inhibitor (BU/mL) | <0.5 | — | — |
| Factor XIII (%) | 130 | — | — |
| Hematuria | Negative | — | — |
| Proteinuria | Negative | — | — |
Cross-mixing tests could not be performed at our hospital.
Ab, antibody; Alb, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Cre, creatinine; FDP, fibrin degradation product; Fib, fibrinogen; Hb, hemoglobin; IgG, immunoglobulin G; LDH, lactate dehydrogenase; Plt, platelets; T-Bil, total bilirubin; TP, total protein; VWF, von Willebrand factor; WBC, white blood cells.